CXCL9 and CXCL10 expression are critical for control of genital herpes simplex virus type 2 infection through mobilization of HSV-specific CTL and NK cells to the nervous system

Journal of Immunology

Volumn 180, Issue 2, 2008, Pages 1098-1106

  Thapa, Manoj ^a   Welner, Robert S ^b   Pelayo, Rosana ^b   Carr, Daniel J J ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; CHEMOKINE; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DISEASE DURATION; EFFECTOR CELL; FEMALE; GENITAL HERPES; HERPES SIMPLEX VIRUS 2; HOST; INFECTION CONTROL; KNOCKOUT MOUSE; LEUKOCYTE; LYMPH NODE; LYMPHATIC DRAINAGE; MOBILIZATION; MORTALITY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; SPINAL CORD; SPLEEN; WILD TYPE; ANIMAL; CELL MOTION; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT;

ANIMALS; CELL MOVEMENT; CENTRAL NERVOUS SYSTEM; CHEMOKINE CXCL10; CHEMOKINE CXCL9; CHEMOKINES; CYTOKINES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; KILLER CELLS, NATURAL; MICE; MICE, MUTANT STRAINS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 40449131101     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.2.1098     Document Type: Article

References (56)

1. Inagaki, K., T. Daikoku, F. Goshima, and Y. Nashiyama. 2000. Impaired induction of protective immunity by highly virulent herpes simplex type 2 in a murine model of genital herpes. Arch. Virol. 145: 1989-2002.
2. + T cells in innate and adaptive immune control of genital herpes simplex virus type 2 infection in mice. J. Gen. Virol. 82: 845-853.
3. Whitley, R. J., and R. L. Miller. 2001. Immunologic approach to herpes simplex virus. Viral Immunol. 14: 2: 111-118.
4. Duerst, R. J., and L. A. Morrison. 2003. Innate immunity to herpes simplex virus type 2. Viral Immunol. 16: 475-490.
5. MasCasullo, V., E. Fam, M. J. Keller, and B. C. Herold. 2005. Role of mucosal immunity preventing genital herpes infection. Viral Immunol. 18: 595-606.
6. Celum, C. L. 2004. The interaction between herpes simplex virus and human immunodeficiency virus. Herpes 11(Suppl. 1): 36A-45A.
7. Strick, L. B., A. Wald, and C. Celum. 2006. Management of herpes simplex virus type 2 infection HIV type 1-infected persons. Clin. Infect. Dis. 43: 347-356.
8. Murdoch, C., and A. Finn. 2000. Chemokine receptors and their role in inflammation and infectious diseases. Blood 95: 3032-3043.
9. Park, M. K., D. Amichay, P. Love, W. Elizabeth, L. Fang, and A. Grienberg. 2002. The CXC chemokine murine monokine induced by IFN-γ (CXC chemokine ligand 9) is made by APCs, targets lymphocytes including activated B cells, and supports antibody responses to a bacterial pathogen in vivo. J. Immunol. 169: 1433-1443.
10. Dufour, J. H., M. Dziejman, M. T. Liu, J. H. Leung, T. E. Lane, and A. D. Luster. 2002. IFN-γ- inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J. Immunol. 168: 3195-3204.
11. Liu, M. T., B. P. Chen, P. Oertel, M. J. Buchmeier, D. Armstrong, T. A. Hamilton, and T. E. Lane. 2000. The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease. J. Immunol. 165: 2327-2330.
12. Kolb, S. A., B. Sporer, F. Lahrtz, U. Koedel, H. W. Pfister, and A. Fontana. 1999. Identification of a T cell chemotactic factor in the cerebrospinal fluid of HIV-1 infected individuals as interferon-γ inducible protein 10. J. Neuroimmunol. 93: 172-181.
13. Khan, I., J. A. MacLean, F. Lee, L. Casciotti, E. DeHaan, J. Schwartzman, and A. Luster. 2000. The IP-10 chemokine is critical for effector T cell trafficking and host survival in Toxoplasma gondii infection. Immunity 12: 483-494.
14. Liu, M. T., H. S. Keirstead, and T. E. Lane. 2001. Neutralization of the chemokine CXCL10 reduces inflammatory cell invasion and demyelination and improves neurological function in a viral model of multiple sclerosis. J. Immunol. 167: 4091-4097.
15. Melchjorsen, J., L. N. Sorensen, and S. R. Paludan. 2003. Expression and function of chemokines during viral infections: from molecular mechanisms to in vivo function. J. Leukocyte Biol. 74: 331-343.
16. Apolinario, A., P. L. Majano, E. Alvarez-Pérez, A. Saez, C. Lozano, J. Varqas, and C. García-Monzón. 2002. Increased expression of T cell chemokines and their receptors in chronic hepatitis C: relationship with the histological activity of liver disease. Am. J. Gastroenterol. 97: 2861-2870.
17. Mahalingam, S., J. M. Farber, and G. Karupiah. 1998. The interferon-inducible chemokines MuMig and Crg-2 exhibit antiviral activity in vivo. J. Virol. 73: 1479-1491.
18. Salazar-Mather, T. P., T. A. Hamilton, and C. A. Biron. 2000. A chemokine-tocytokine-to-chemokine cascade critical in antiviral defense. J. Clin. Invest. 105: 985-993.
19. Liu, M. T., D. Armstrong, T. A. Hamilton, and T. E. Lane. 2001. Expression of Mig (monokine induced by interferon-γ) is important in T lymphocyte recruitment and host defense following viral infection of central nervous system. J. Immunol. 166: 1790-1795.
20. McDermott, M. R., C. H. Goldsmith, K. L. Rosenthal, and L. J. Brais. 1989. T lymphocytes in genital lymph nodes protect mice from intravaginal infection with herpes simplex virus type 2. J. Infect. Dis. 159: 460-466.
21. Parr, M. B., and E. L. Parr. 1998. Mucosal immunity to herpes simplex virus type 2 in the mouse vagina is impaired by in vivo depletion of T lymphocytes. J. Virol. 72: 2677-2685.
22. Koelle, D. M., C. M. Posavad, G. R. Barnum, M. L. Johnson, J. M. Frank, and L. Corey. 1998. Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes. J. Clin. Invest. 101: 1500-1508.
23. Morrison, L. A., L. Zhu, and L. G. Thebeau. 2001. Vaccine-induced serum immunoglobulin contributes to protection from herpes simplex virus type 2 genital infection in the presence of immune T cells. J. Virol. 75: 1195-1204.
24. Cunningham, A. L., and Z. Mikloska. 2001. The Holy Grail: immune control of human herpes simplex virus infection and disease. Herpes 8(Suppl. 1): 6A-9A.
25. + T cells requires γ interferon and either perforin- or fas-mediated cytolytic mechanisms. J. Virol. 79: 14546-14554.
26. Pardo, J., S. Balkow, A. Anel, and M. M. Simon. 2002. The differential contribution of granzyme A and granzyme B in cytotoxic T lymphocyte-mediated apoptosis is determined by the quality of target cells. Eur. J. Immunol. 32: 1980-1985.
27. Biron, C. A., K. B. Nyugen, G. C. Pien, L. P. Cousins, and T. P. Salazar-Mather. 1999. Natural killer cells in antiviral defense: functions and regulation by innate cytokines. Annu. Rev. Immunol. 17: 189-220.
28. Ashkar, A. A., and K. L. Rosenthal. 2003. Interleukin-15 and natural killer and NKT cells play a critical role in innate protection against genital herpes simplex virus type 2 infection. J. Virol. 77: 10168-10171.
29. Milligan, G. N., D. I. Bernstein, and N. Bourne. 1998. T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2. J. Immunol. 160: 6093-6100.
30. + T-cell-mediated protective immunity against herpes simplex virus type 2 in vivo. J. Virol. 74: 11173-11180.
31. Di Santo, J. P. 2006. Natural killer cell developmental pathways: a question of balance. Annu. Rev. Immunol. 24: 257-286.
32. Thapa, M., W. A. Kuziel, and D. J. J. Carr. 2007. Susceptibility of CCR5 mice is linked to NK cell mobilization. J. Virol. 81: 3704-3713.
33. Singh, R., A. Kumar, W. D. Creery, M. Ruben, A. Giulivi, and F. Diaz-Mitoma. 2003. Dysregulated expression of IFN-γ and IL-10 and impaired IFN-γ-mediated responses at different disease stages in patients with genital herpes simplex virus-2 infection. Clin. Exp. Immunol. 133: 97-107.
34. Parr, M. B., and E. L. Parr. 1999. The role of γ interferon in immune resistance to vaginal infection by herpes simplex virus type 2 in mice. Virology 258: 282-294.
35. + effector T cells involved in immune surveillance of the lymphocytic choriomeningitis virus-infected central nervous system. J. Immunol. 176: 4235-4243.
36. Ghersa, P., M. Gelati, J. Colinge, G. Feger, C. Power, R. Papoin, and A. Salmaggi. 2002. MIG-differential gene expression in mouse brain endothelial cells. Neuroreport. 13: 9-14.
37. Härle, P., V. F. Cull, M. P. Agbaga, R. F. Silverman, B. R. Williams, C. James, and D. J. Carr. 2002. Differential effect of murine α/β interferon transgenes on antagonization of herpes simplex virus type 1 replication. J. Virol. 76: 6558-6567.
38. Skinner, P. J., M. Daniels, C. S. Schmidt, S. C. Jameson, and A. T. Haase. 2000. Cutting edge: in situ tetramer staining of antigen-specific T cells in tissues. J. Immunol. 165: 613-617.
39. Ireland, D. D. C., and C. S. Reiss. 2006. Gene expression contributing to recruitment of circulating cells in response to vesicular stomatitis virus infection of CNS. Viral Immunol. 19: 535-545.
40. Asensio, V. C., and I. L. Campbell. 1997. Chemokine gene expression in brains of mice with lymhocytic choriomeninigitis. J. Virol. 71: 7832-7840.
41. Glass, W. G., B. P. Chen, M. T. Liu, and T. E. Lane. 2002. Mouse hepatitis virus infection of the central nervous system: chemokine mediated regulation of host defense and disease. Viral Immunol. 15: 262-272.
42. Dos Santos, A. C., M. M. Barsante, R. M. Esteves Arantes, C. C. Bernard, M. M. Teixeira, and J. Carvalho-Tavares. 2005. CCL2 and CCL5 mediate leukocyte adhesion in experimental autoimmune encephalomyelitis: an intravital microscopy study. J. Neuroimmunol. 162: 122-129.
43. Wickham, S. B., B. Lu, J. Ash, and D. J. J. Carr. 2005. Chemokine receptor deficiency is associated with increased chemokine expression in the peripheral and central nervous systems and increased resistance to herpetic encephalitis. J. Neuroimmunol. 162: 51-59.
44. Carr, D. J. J., J. Ash, T. E. Lane, and W. A. Kuziel. 2006. Abnormal immune response of CCR5-deficient mice to ocular infection with herpes simplex virus type 1. J. Gen. Virol. 87: 490-499.
45. Kurt-Jones, E. A., M. Chan, S. Zhou, J. Wang, G. Reed, R. Bronson, M. M. Arnold, D. M. Knipe, and R. M. Finberg. 2004. Herpes simplex virus 1 interaction with toll-like receptor 2 contributes to lethal encephalitis. Proc. Natl. Acad. Sci. USA 101: 1315-1320.
46. Sánchez-Burgos, G., R. Hernández-Pando, I. L. Campbell, J. Ramos-Casteñada, and C. Ramos. 2004. Cytokine production in brain of mice experimentally infected with dengue virus. Neuroreport. 15: 37-42.
47. Bonwetsch, R., S. Croul, M. W. Richardson, C. Lorenzana, L. D. Valle, A. E. Sverstiuk, S. Amini, S. Morgello, K. Khalili, and J. Rappaport. 1999. Role of HIV-1 tat and CC chemokine Mip-1α in the pathogenesis of HIV associated central nervous system disorders. J. Neurovirol. 5: 685-694.
48. Seebach, J., D. Bartholdi, K. Frei, K. S. Spanaus, E. Ferrero, U. Widmer, S. Isenmann, R. M. Strieter, M. Schwab, and H. Pfister. 1995. Experimental Listeria meninigoencephalitis: macrophage inflammatory protein-1 and -2 produced intrathecally and mediate chemotactic activity in cerebrospinal fluid of infected mice. J. Immunol. 155: 4367-4375.
49. Zou, J. Y., and F. T. Crews. 2005. TNFα potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NF κB inhibition. Brain Res. 1034: 11-24.
50. Milligan, G. N., K. L. Dudley-McClain, C. G. Young, and C. F. Chu. 2004. T-cell-mediated mechanisms involved in resolution of genital herpes simplex virus type 2 (HSV-2) infection of mice. J. Reprod. Immunol. 61: 115-127.
51. Nuovo, G. J., D. L. Defaria, J. G. Chanona-Vilchi, and Y. Zhang. 2005. Molecular detection of rabies encephalitis and correlation with cytokine expression. Mod. Pathol. 18: 62-67.
52. Sternberg, J. M., J. Rodgers, B. Bradley, L. Maclean, M. Murray, and P. G. Kennedy. 2005. Meningoencephalitic African trypanosomiasis: brain IL-10 and IL-6 are associated with protection from neuron-inflammatory pathology. J. Neuroimmunol. 167: 81-89.
53. Harandi, A. M., B. Svennerholm, J. Holmgren, and K. Eriksson. 2001. Interleukin-12 (IL-12) and IL-18 are important in innate defense against genital herpes simplex virus type 2 infection in mice but are not required for the development of acquired γ interferon-mediated protective immunity. J. Virol. 75: 6705-6709.
54. Kagi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369: 31-37.
55. Rossi, C. P., A. McAllister, M. Tanguy, D. Kagi, and M. Brahic. 1998. Theiler's virus infection of perforin deficient mice. J. Virol. 72: 4515-4519.
56. Kagi, D., and H. Hengartner. 1996. Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses. Curr. Opin. Immunol. 8: 472-477.